Someone else's clock has started running against them: the company is being paid to solve a problem that is already cost
The model's full reasoning — Q2 2022 call → NOWe need determine if management describes counterparties already losing something real and ongoing, and behaving as if meter running. Need answer YES/NO based only transcript. We need parse call. Company Treace Medical Concepts, bunion surgery Lapiplasty. Management discusses growth, surgeon adoption, DTC, direct sales. Do they describe customers (surgeons/patients) currently accumulating loss because they don't have product? They mention large underserved market, recurrence rates of osteotomy as high as 78%, limitations of current standard. But is that a running meter? They say patients suffer from painful lifestyle limiting bunions, recurrence rates. But do they describe counterparties already acting like meter running? They say surgeons enthusiastic, training courses book to capacity, active surgeon base increases, direct sales reps penetrate faster. But is that because waiting costs them? Not really. They talk about surgeon demand for training, adoption, but not that surgeons are losing money/output because they don't use product. The "running meter" might be patients' suffering, but not described as accumulating loss that stops when company delivers? They mention 1.1 million candidates, only 450k undergo surgery due to limitations, recurrence rates. But management doesn't describe that patients are currently losing something in a way that makes them chase company. They describe DTC programs educating patients and connecting with surgeons. That is demand creation, not counterparties driven by ongoing losses. Let's examine for any mention of "cost of delay" on counterparty side. They discuss reimbursement increases, but not loss. They discuss surgeon training and adoption. They say "we're the only industry participant with growing body of clinical data demonstrating rapid return to weight-bearing..." That's benefit, not running meter. They say "positive patient-reported outcome scores." Benefits. Question requires both halves: (1) running meter on other side (customers/patients/surgeons currently accumulating cost/loss until company delivers), and (2) other side already acting like meter running (pressing, paying more, committing, etc.). Also management conveys dynamic generating business meaningful and ahead. Need answer YES only if both present.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| TACT | TransAct Technologies Incorporated | Q4 2022 | 2023-03-08 | A |
| CRL | Charles River Laboratories International | Q2 2022 | 2022-08-03 | C |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| GTES | Gates Industrial Corporation plc | Q4 2021 | 2022-02-07 | C+ |
SYM · Q3 2022 → YESThe question is: Does management describe that ITS COUNTERPARTIES ARE ALREADY LOSING SOMETHING REAL AND ONGOING — money, output, access, standing, time, or an opportunity of their own — FOR AS LONG AS...YES The transcript shows management describing customers' ongoing pain from labor shortages and broken supply chains that prevent them from handling demand, with customers actively clamoring for faster deployments and wanting the system as quickly as possible.
CRL · Q2 2022 → YESThe question is whether management describes that their counterparties are already losing something real and ongoing — money, output, access, standing, time, or an opportunity — for as long as they do...
GTES · Q4 2021 → YESThe question is: Does management describe that ITS COUNTERPARTIES ARE ALREADY LOSING SOMETHING REAL AND ONGOING — money, output, access, standing, time, or an opportunity of their own — FOR AS LONG AS...